Integrin-associated protein association with src homology 2 domain containing tyrosine phosphatase substrate 1 regulates IGF-i signaling in vivo

Diabetes

Volumn 57, Issue 10, 2008, Pages 2637-2643

  Maile, Laura A ^a   Capps, Byron E ^a   Miller, Emily C ^a   Aday, Ariel W ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD47 ANTIGEN; GELATINASE A; GLUCOSE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN SHC; PROTEIN TYROSINE PHOSPHATASE SHP; SOMATOMEDIN BINDING PROTEIN 1; CHOLESTEROL; IMMUNOGLOBULIN RECEPTOR; PTPNS1 PROTEIN, MOUSE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; AORTA; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME REGULATION; ENZYME SUBSTRATE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN BINDING; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIGENS, CD47; BLOOD GLUCOSE; CELL PROLIFERATION; CELLS, CULTURED; CHOLESTEROL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; HUMANS; HYPERGLYCEMIA; IMMUNOBLOTTING; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS;

EID: 58149340146     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-0326     Document Type: Article

References (34)

1. Kannel WB, McGee DL: Diabetes and cardiovascular risk factors: the Framingham study. Circulation 59:8-13, 1979
2. Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
3. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, O'Leary DH, Genuth S: Intensive diabetes therapy and carotid intima- media thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303, 2003
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653, 2005
5. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362:801-809, 1993
6. Jones JI, Prevette T, Gockerman A, Clemmons DR: Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. Proc Natl Acad Sci USA 93:2482-2487, 1996
7. Cercek B, Fishbein MC, Forrester JS, Helfant RH, Fagin JA: Induction of insulin-like growth factor I messenger RNA in rat aorta after balloon denudation. Circ Res 66:1755-1760, 1990
8. Hayry P, Myllarniemi M, Aavik E, Alatalo S, Aho P, Yilmaz S, Raisanen- Sokolowski A, Cozzone G, Jameson BA, Baserga R: Stabile D-peptide analog of insulin-like growth factor-1 inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 9:1336-1344, 1995
9. Maile LA, Capps BE, Ling Y, Xi G, Clemmons DR: Hyperglycemia alters the responsiveness of smooth muscle cells to insulin-like growth factor-I. Endocrinology 148:2435-2443, 2007
10. Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR: IGF-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the {beta}3 subunit of {alpha}V{beta}3. Mol Endocrinol 20:881-892, 2006
11. Ling Y, Maile LA, Lieskovska J, Badley-Clarke J, Clemmons DR: Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. Mol Biol Cell 16:3353-3364, 2005
12. Maile LA, Badley-Clarke J, Clemmons DR: The association between integrin-associated protein and SHPS-1 regulates insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Mol Biol Cell 14:3519-3528, 2003
13. Maile LA, Clemmons DR: Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ Res 93:925-931, 2003
14. Maile LA, Capps BE, Miller EC, Allen LB, Veluvolu U, Aday AW, Clemmons DR: Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I. Mol Endocrinol 22:1226-1237, 2008
15. Hsueh W, Abel ED, Breslow JL, Maeda N, Davis RC, Fisher EA, Dansky H, McClain DA, McIndoe R, Wassef MK, Rabadan-Diehl C, Goldberg IJ: Recipes for creating animal models of diabetic cardiovascular disease. Circ Res 100:1415-1427, 2007
16. Gockerman A, Prevette T, Jones JI, Clemmons DR: Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology 136:4168-4173, 1995
17. Tamura K, Kanzaki T, Tashiro J, Yokote K, Mori S, Ueda S, Saito Y, Morisaki N: Increased atherogenesis in Otsuka Long-Evans Tokushima fatty rats before the onset of diabetes mellitus: association with overex- pression of PDGF beta-receptors in aortic smooth muscle cells. Atherosclerosis 149:351-358, 2000
18. Campbell M, Trimble ER: Modification of PI3K- and MAPK-dependent chemotaxis in aortic vascular smooth muscle cells by protein kinase CbetaII. Circ Res 96:197-206, 2005
19. Mori S, Takemoto M, Yokote K, Asaumi S, Saito Y: Hyperglycemia-induced alteration of vascular smooth muscle phenotype. J Diabetes Complications 16:65-68, 2002
20. Harrington SC, Simari RD, Conover CA: Genetic deletion of pregnancy- associated plasma protein-A is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet. Circ Res 100:1696-1702, 2007
21. Zhu B, Zhao G, Witte DP, Hui DY, Fagin JA: Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury. Endocrinology 142:3598-3606, 2001
22. Sajid M, Hu Z, Guo H, Li H, Stouffer GA: Vascular expression of integrin- associated protein and thrombospondin increase after mechanical injury. J Investig Med 49:398-406, 2001
23. Stenina OI, Krukovets I, Wang K, Zhou Z, Forudi F, Penn MS, Topol EJ, Plow EF: Increased expression of thrombospondin-1 in vessel wall of diabetic Zucker rat. Circulation 107:3209-3215, 2003
24. Zhou Y, Poczatek MH, Berecek KH, Murphy-Ullrich JE: Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 339:633-641, 2006
25. Zhang XM, Shen F, Xv ZY, Yan ZY, Han S: Expression changes of thrombospondin-1 and neuropeptide Y in myocardium of STZ-induced rats. Int J Cardiol 105:192-197, 2005
26. Belmadani S, Bernal J, Wei CC, Pallero MA, Dell'italia L, Murphy-Ullrich JE, Berecek KH: A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin II. Am J Pathol 171:777-789, 2007
27. Raman P, Krukovets I, Marinic TE, Bornstein P, Stenina OI: Glycosylation mediates up-regulation of a potent antiangiogenic and proatherogenic protein, thrombospondin-1, by glucose in vascular smooth muscle cells. J Biol Chem 282:5704-5714, 2007
28. Newby AC: Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev 85:1-31, 2005
29. Kuzuya M, Nakamura K, Sasaki T, Cheng XW, Itohara S, Iguchi A: Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26:1120-1125, 2006
30. Bendeck MP, Irvin C, Reidy MA: Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ Res 78:38 -43, 1996
31. Webb KE, Henney AM, Anglin S, Humphries SE, McEwan JR: Expression of matrix metalloproteinases and their inhibitor TIMP-1 in the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 17:1837-1844, 1997
32. Liu Y, Wang Z, Yin W, Li Q, Cai M, Zhang C, Xiao J, Hou H, Li H, Zu X: Severe insulin resistance and moderate glomerulosclerosis in a minipig model induced by high-fat/high-sucrose/high-cholesterol diet. Exp Anim 56:11-20, 2007
33. Gharagozlian S, Henriksen T, Kolset SO: High glucose and Nepsilon- (carboxymethyl) lysine bovine serum albumin modulate release of matrix metalloproteinases in cultured human endothelial cells. Eur J Nutr 45:283-290, 2006
34. Polhill TS, Saad S, Poronnik P, Fulcher GR, Pollock CA: Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure. Am J Physiol Renal Physiol 287:F268-F273, 2004